VAGILAC Trademark

Trademark Overview


On Thursday, January 9, 1947, a trademark application was filed for VAGILAC with the United States Patent and Trademark Office. The USPTO has given the VAGILAC trademark a serial number of 71515523. The federal status of this trademark filing is EXPIRED as of Tuesday, November 3, 1992. This trademark is owned by U. S. VITAMIN CORPORATION. The VAGILAC trademark is filed in the Pharmaceutical Products category with the following description:

CRYSALLINE POLYMER OF LACTIC ACID WITH LACTOSE U.S.P., TO BE USED IN THE TREATMENT OF TRICHOMONAS VAGINITIS AND CERTAIN OTHER VAGINAL INFECTIONS
vagilac

General Information


Serial Number71515523
Word MarkVAGILAC
Filing DateThursday, January 9, 1947
Status900 - EXPIRED
Status DateTuesday, November 3, 1992
Registration Number0442448
Registration DateTuesday, April 12, 1949
Mark Drawing5000 - Drawing with word(s) / letter(s) / number(s) in Stylized form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesCRYSALLINE POLYMER OF LACTIC ACID WITH LACTOSE U.S.P., TO BE USED IN THE TREATMENT OF TRICHOMONAS VAGINITIS AND CERTAIN OTHER VAGINAL INFECTIONS

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes018
Class Status Code9 - Expired
Class Status DateTuesday, November 3, 1992
Primary Code018
First Use Anywhere DateWednesday, October 23, 1946
First Use In Commerce DateWednesday, October 23, 1946

Trademark Owner History


Party NameU. S. VITAMIN CORPORATION
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressNEW YORK, NY

Trademark Events


Event DateEvent Description
Tuesday, November 3, 1992EXPIRED SEC. 9
Saturday, April 12, 1969REGISTERED AND RENEWED (FIRST RENEWAL - 20 YRS)